Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

A Strategy to Improve Implementation of LTVV for Patients w/ ARDS

Not Applicable

Withdrawn

Conditions: Acute Respiratory Distress Syndrome

Interventions: Behavioral: Multi-component LTVV implementation strategy

First Posted Date: 2017-02-13

Last Posted Date: 2020-03-06

Lead Sponsor: Northwestern University

Registration Number: NCT03051139

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

Not Applicable

Completed

Conditions: Psoriasis
Atopic Dermatitis
Ichthyosis

Interventions: Other: Stigma Questionnaire and Interview
Other: Itch Questionnaire and Interview
Other: Cognitive Interview and PROMIS Itch Questionnaire

First Posted Date: 2017-02-13

Last Posted Date: 2020-10-09

Lead Sponsor: Northwestern University

Target Recruit Count: 943

Registration Number: NCT03051347

Locations: 🇺🇸
Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital, Chicago, Illinois, United States

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase 2

Conditions: Stage IV Non-Small Cell Lung Cancer
Recurrent Non-Small Cell Lung Carcinoma
Stage III Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer

Interventions: Other: Laboratory Biomarker Analysis
Drug: Metformin Hydrochloride
Biological: Nivolumab

First Posted Date: 2017-02-09

Last Posted Date: 2020-10-14

Lead Sponsor: Northwestern University

Target Recruit Count: 17

Registration Number: NCT03048500

Locations: 🇺🇸
Northwestern University- Lake Forest Hospital, Lake Forest, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia

Phase 2

Withdrawn

Conditions: Androgenetic Alopecia

Interventions: Device: Platelet Rich Plasma Prep System
Drug: Placebo

First Posted Date: 2017-02-09

Last Posted Date: 2021-12-23

Lead Sponsor: Northwestern University

Registration Number: NCT03048461

Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery

Phase 2

Conditions: Stage IIIB Breast Cancer
Estrogen Receptor Negative
HER2/Neu Negative
Stage III Breast Cancer
Triple-Negative Breast Carcinoma
Progesterone Receptor Negative
Recurrent Breast Carcinoma
Stage IIIA Breast Cancer
Stage IV Breast Cancer
Stage IIIC Breast Cancer

Interventions: Drug: Capecitabine
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab

First Posted Date: 2017-02-07

Last Posted Date: 2020-07-13

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT03044730

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States

Barriers to Care and QOL for CCCA Patients

Completed

Conditions: Central Centrifugal Cicatricial Alopecia
Scarring Alopecia
Central Centrifugal Scarring Alopecia

First Posted Date: 2017-02-07

Last Posted Date: 2017-12-13

Lead Sponsor: Northwestern University

Target Recruit Count: 34

Registration Number: NCT03044782

Locations: 🇺🇸
Northwestern University Department of Dermatology, Chicago, Illinois, United States

Mechanical Support Measures of Adjustment and QOL

Completed

Conditions: Heart Failure
Quality of Life
Cardiovascular Diseases

First Posted Date: 2017-02-07

Last Posted Date: 2022-02-16

Lead Sponsor: Northwestern University

Target Recruit Count: 895

Registration Number: NCT03044535

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
St. Vincent Hospital, Indianapolis, Indiana, United States

and more 9 locations

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses

Phase 2

Completed

Conditions: Lamellar Ichthyosis
Ichthyosis
Autosomal Recessive Congenital Ichthyosis
Congenital Ichthyosiform Erythroderma
Epidermolytic Ichthyosis
Netherton Syndrome

Interventions: Drug: Placebo
Drug: Secukinumab

First Posted Date: 2017-02-02

Last Posted Date: 2021-08-25

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT03041038

Locations: 🇺🇸
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸
Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, New York, United States

Early Amniotomy Versus Delayed Amniotomy Following Foley Catheter Ripening in Nulliparous Labor Induction

Not Applicable

Completed

Conditions: Labor Induction

Interventions: Procedure: Amniotomy
Device: Foley Catheter
Drug: Misoprostol

First Posted Date: 2017-02-01

Last Posted Date: 2023-04-03

Lead Sponsor: Northwestern University

Target Recruit Count: 69

Registration Number: NCT03039036

Locations: 🇺🇸
Prentice Women's Hospital, Chicago, Illinois, United States

Postpartum Opioid Prescribing Patterns and Patient Utilization

Completed

Conditions: Postpartum
Opioid Use
Post-operative
Cesarean Delivery

Interventions: Other: Survey

First Posted Date: 2017-01-25

Last Posted Date: 2020-02-25

Lead Sponsor: Northwestern University

Target Recruit Count: 494

Registration Number: NCT03030742

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy